Literature DB >> 11515893

Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding.

M M Wilkes1, R J Navickis, W J Sibbald.   

Abstract

BACKGROUND: This meta-analysis tested the hypothesis that cumulative blood loss during the first 24 hours after cardiopulmonary bypass is lower in patients exposed to albumin than hydroxyethyl starch (HES).
METHODS: Randomized controlled trials comparing albumin and HES in cardiopulmonary bypass patients were identified by bibliographic database searches and other methods.
RESULTS: Sixteen trials involving 653 randomized patients were included. In 88% of randomized comparisons, postoperative bleeding was lower in the albumin group, and the standardized mean difference in bleeding favoring albumin across all trials (-0.24; 95% confidence interval, -0.40 to -0.08) was statistically significant. Bleeding differences between albumin and either high or medium molecular weight HES were similar. In trials of adults, the pooled mean blood loss in the albumin group was 693+/-350 mL compared with 789+/-487 mL in the HES group. The estimated proportion of adult albumin group patients with blood loss of more than 1,000 mL was 19% compared with 33% of adult HES group patients. Conclusions. Postoperative blood loss is significantly lower in cardiopulmonary bypass patients exposed to albumin than HES.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11515893     DOI: 10.1016/s0003-4975(01)02745-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  35 in total

1.  Why albumin may still work.

Authors:  Johan Groeneveld
Journal:  Wien Klin Wochenschr       Date:  2004-05-31       Impact factor: 1.704

Review 2.  [Volume replacement therapy options for critically ill patients].

Authors:  C J Wiedermann
Journal:  Med Klin Intensivmed Notfmed       Date:  2011-10-07       Impact factor: 0.840

Review 3.  Perioperative fluid and electrolyte management in cardiac surgery: a review.

Authors:  Robert Young
Journal:  J Extra Corpor Technol       Date:  2012-03

4.  5 Human Albumin.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

Review 5.  Hydroxyethyl starch for cardiovascular surgery: a systematic review of randomized controlled trials.

Authors:  Xue-Yin Shi; Zui Zou; Xing-Ying He; Hai-Tao Xu; Hong-Bin Yuan; Hu Liu
Journal:  Eur J Clin Pharmacol       Date:  2011-03-02       Impact factor: 2.953

Review 6.  Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies.

Authors:  Romuald Bellmann; Clemens Feistritzer; Christian J Wiedermann
Journal:  Clin Pharmacokinet       Date:  2012-04-01       Impact factor: 6.447

Review 7.  Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review.

Authors:  Christiane S Hartog; Dorit Reuter; Wolfgang Loesche; Michael Hofmann; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2011-10-12       Impact factor: 17.440

Review 8.  Controversies in fluid therapy: Type, dose and toxicity.

Authors:  Robert C McDermid; Karthik Raghunathan; Adam Romanovsky; Andrew D Shaw; Sean M Bagshaw
Journal:  World J Crit Care Med       Date:  2014-02-04

9.  Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine model.

Authors:  F Kaspereit; S Hoffmann; I Pragst; G Dickneite
Journal:  Br J Anaesth       Date:  2010-08-17       Impact factor: 9.166

10.  [Study protocol of the VISEP study. Response of the SepNet study group].

Authors:  K Reinhart; F M Brunkhorst; C Engel; F Bloos; A Meier-Hellmann; M Ragaller; N Weiler; O Moerer; M Gruendling; M Oppert; S Grond; D Olthoff; U Jaschinski; S John; R Rossaint; T Welte; M Schaefer; P Kern; E Kuhnt; M Kiehntopf; T Deufel; C Hartog; H Gerlach; F Stüber; H-D Volk; M Quintel; M Loeffler
Journal:  Anaesthesist       Date:  2008-07       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.